A Phase II Double-Blind Study of Topical Tretinoin With or Without Oral 4-HPR (Fenretinide) in Patients With the Dysplastic Nevus Syndrome
Phase of Trial: Phase II
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Fenretinide (Primary) ; Tretinoin (Primary)
- Indications Skin cancer
- Focus Therapeutic Use
- 24 Mar 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 03 Sep 2005 New trial record.